Sustained release of nerve growth factor from biodegradable polymer microspheres
- PMID: 1620291
- DOI: 10.1227/00006123-199203000-00001
Sustained release of nerve growth factor from biodegradable polymer microspheres
Abstract
Although grafted adrenal medullary tissue to the striatum has been used both experimentally and clinically in parkinsonism, there is a definite need to augment long-term survival. Infusion of nerve growth factor (NGF) or implantation of NGF-rich tissue into the area of the graft prolongs survival and induces differentiation into neural-like cells. To provide for prolonged, site-specific delivery of this growth factor to the grafted tissue in a convenient manner, we fabricated biodegradable polymer microspheres of poly(L-lactide)co-glycolide (70:30) containing NGF. Biologically active NGF was released from the microspheres, as assayed by neurite outgrowth in a dorsal root ganglion tissue culture system. Anti-NGF could block this outgrowth. An enzyme-linked immunosorbent assay detected NGF still being released in vitro for longer than 5 weeks. In vivo immunohistochemical studies showed release over a 4.5-week period. This technique should prove useful for incorporating NGF and other growth factors into polymers and delivering proteins and other macromolecules intracerebrally over a prolonged time period. These growth factor-containing polymer microspheres can be used in work aimed at prolonging graft survival, treating experimental Alzheimer's disease, and augmenting peripheral nerve regeneration.
Similar articles
-
Polyphosphoester microspheres for sustained release of biologically active nerve growth factor.Biomaterials. 2002 Sep;23(17):3765-72. doi: 10.1016/s0142-9612(02)00116-3. Biomaterials. 2002. PMID: 12109702
-
Neurotrophin releasing single and multiple lumen nerve conduits.J Control Release. 2005 Jun 2;104(3):433-46. doi: 10.1016/j.jconrel.2005.02.022. J Control Release. 2005. PMID: 15911044 Free PMC article.
-
Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders.Biomaterials. 1999 Feb;20(4):329-39. doi: 10.1016/s0142-9612(98)00172-0. Biomaterials. 1999. PMID: 10048405
-
Biodegradable poly(DL-lactide-co-glycolide) microspheres.Res Immunol. 1992 Jun;143(5):557-63; discussion 581. doi: 10.1016/0923-2494(92)80069-w. Res Immunol. 1992. PMID: 1439138 Review. No abstract available.
-
Nerve growth factor delivery systems.J Control Release. 1998 Apr 30;53(1-3):1-6. doi: 10.1016/s0168-3659(97)00232-0. J Control Release. 1998. PMID: 9741908 Review.
Cited by
-
Urine-derived stem cells for potential use in bladder repair.Stem Cell Res Ther. 2014 May 28;5(3):69. doi: 10.1186/scrt458. Stem Cell Res Ther. 2014. PMID: 25157812 Free PMC article. Review.
-
Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors.Biomaterials. 2013 Jan;34(4):1311-26. doi: 10.1016/j.biomaterials.2012.10.038. Epub 2012 Nov 6. Biomaterials. 2013. PMID: 23137393 Free PMC article.
-
Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.Pharm Res. 1999 Feb;16(2):232-40. doi: 10.1023/a:1018824324275. Pharm Res. 1999. PMID: 10100308
-
Distribution of drugs following controlled delivery to the brain interstitium.J Neurooncol. 1995 Nov;26(2):91-102. doi: 10.1007/BF01060215. J Neurooncol. 1995. PMID: 8787851 Review.
-
Localized delivery of proteins in the brain: can transport be customized?Pharm Res. 1998 Mar;15(3):377-85. doi: 10.1023/a:1011911912174. Pharm Res. 1998. PMID: 9563066 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources